Company: ANY
Filing Date: 2025-12-05
Form Type: DEF 14A
Source: 0001591956-25-000025
Chunk: 20

Company: Sphere 3D Corp.
Filing Date: 2025-12-05
Form: DEF 14A
Chunk 20
---
 Common Shares 
                     (1) |     |    |     | Beneficial Ownership 
 (2)                  |
| Armistice Capital, LLC                                              |     |               2,231,594 |     | -3 |     | 6.6%                 |
| 510 Madison Ave., 7th Floor, New York, New York 10022               |     |                         |     |    |     |                      |
| Kurt L. Kalbfleisch                                                 |     |                 775,234 |     | -4 |     | 2.3%                 |
| Timothy Hanley                                                      |     |                 143,872 |     | -5 |     | *                    |
| Susan S. Harnett                                                    |     |                 126,300 |     | -6 |     | *                    |
| Duncan McEwan                                                       |     |                 290,399 |     | -7 |     | *                    |
| All current directors and executive officers as a group (4 persons) |     |               1,335,805 |     |    |     | 3.9%                 |

____________________

* Less than 1%

(1) These amounts include common shares, which could be acquired upon exercise or vesting of outstanding convertible securities within 60 days.

(2) Based on 33,729,165 common shares outstanding as of November 24, 2025.

(3) These shares include 2,231,594 common shares held directly by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the “

#### Master Fund
”), and may be deemed to be beneficially owned by: (i) Armistice Capital, LLC (“

#### Armistice Capital
”), as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. These shares do not include common share warrants held by Armistice Capital. Armistice Capital holds (i) 8,736,422 common share warrants for the purchase of 8,736,422 common shares with an exercise price of $0.94 with an initial exercise date on the date of shareholder approval of the warrants (see Proposal No. 1). These warrants are subject to a beneficial ownership limitation of 9.99%, which such limitation restricts the beneficial owner from exercising that portion of the warrants that would result in the beneficial owner and its affiliates owning, after exercise, a